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Postoperative pain management is an advantage of 
minimally invasive surgery, along with reduced morbidity, 
decreased hospital length of stay, and improved patient 
satisfaction scores.
As patients experience less pain, they consume less 
postoperative pain medication and perhaps less narcotic 
medications.  This may lead to fewer nurse interventions 
and thus a reduction in the cost associated to deliver that 
care.
Robotic Surgery is the most advanced minimally invasive 
technique presently available compared to standard 
laparoscopy.  
Advantages of robotic technology over standard 
laparoscopy include:
•  Tools with six degrees of rotational freedom which 
enables the surgeon to make dexterous hand motions
•  3-D, high-definition view of the operative field
•  Ergonomically designed console which decreases 
surgeon’s fatigue
A Cost Analysis of Postoperative Pain Management in Endometrial Cancer Patients:
Robotic Surgery vs. Laparoscopy Surgery
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Background: Table 1. Patient Demographics





  Initial Pain Score
 Mean 2.1 3.0  
 SD 2.48 2.61 0.012
 2nd Pain Score
 Mean 2.8 2.5  
SD 2.65 2.65 0.396
3rd Pain Score
Mean 2.2 2.2  
SD 2.38 2.47 0.929
4th Pain Score
Mean 2.8 3.1  
SD 2.32 2.63 0.566
5th Pain Score   
Mean 2.3 2.6  
SD 2.52 2.54 0.504






Narcotic drug interventions 17 43
Non-narcotic drug interventions 4 9 .860
Total drug interventions 21 52
Non-drug interventions 32 12 .00000371
2nd INTERVENTION
Narcotic drug interventions 33 42
Non-narcotic drug interventions 12 10 .383
Total drug interventions 45 52
Non-drug interventions 10 7 .344
3rd INTERVENTION
Narcotic drug interventions 25 31
Non-narcotic drug interventions 11 12 .796
Total drug interventions 36 43  
Non-drug interventions 8 9 .911
4th INTERVENTION  
Narcotic drug interventions 30 29  
Non-narcotic drug interventions 10 14 .448
Total drug interventions 40 43
Non-drug interventions 14 7 .130
5th INTERVENTION
Narcotic drug interventions 11 19
Non-narcotic drug interventions 9 10 .458
Total drug interventions 20 29  
Non-drug interventions 5 5 .592
Total narcotic drug interventions 
over 24 hour period 116 164
Total non-narcotic drug 
Interventions over 24 hour period 46 55 0.473
Total drug interventions over 24 
hour period 162 219
Total non-drug interventions over 





  Age (y)
 Mean 61.8 63.6 .241
 SD 11.7 11.3
 BMI (kg/m2)











n 31 53 .322
Mean 18.6 16.5  
SD 10.1 7.3
Total Pelvic Nodes   
Mean 14.1 12.2 .141
SD 7.3 4.7
Total Periaortic Nodes






To compare the postoperative pharmacotherapeutic pain 
management in endometrial cancer patients who had a 
robotic-assisted or laparoscopic-assisted hysterectomy 
with/without lymph node dissections
Primary outcomes:
 •  Patient-recorded pain scores
 •  Nursing pain management interventions
Secondary outcomes:
 •  Cost of postoperative pain medication
Objective:
Total Postoperative Pain Management Interventions:
Narcotic vs. Non-narcotic Drug Usage over a 24 Hr Period
Total Postoperative Pain Management Interventions:
Drug vs. Non-drug Interventions over a 24 Hr Period
Average Pain Medication Cost
During Patient Hospital Stay
Average Patient Recorded Pain
Over a 24 Hr Postoperative Period
•  Pain scores and nursing interventions were analyzed for five intervals over a 
24-hour postoperative period, beginning once the patient entered the floor.
•  Nursing interventions were categorized as either a drug or non-drug 
intervention.
•  Drug interentions were subcategorized as narcotic or non-narcotic.
•  Data was analyzed using Student’s t-tests and Pearson’s X2 tests in SPSS.
•  This is an IRB approved, retrospective cohort study.
Methods:
Two hundred fifteen (101 robotic and 114 laparoscopic) patients met the 
inclusion criteria.  There were no significant differences between the two 
groups in age, BMI, clinical stage, comorbidities, lymph nodes retrieved, 
and the number of narcotic v. non-narcotic drug interventions administered. 
Primary outcomes:
 •  Robotic patients had a lower number of initial drug interventions (21 vs 
52; P<.01) and total drug interventions (162 vs 219; P<.01).  The robotic 
cohort also had a lower initial patient-recorded pain score (2.1 vs 3.0; 
P=.012).  
Secondary outcomes:
 •  There was a 50% reduction in the postoperative pain medication cost 
on the day of surgery for robotic patients ($12.24 vs $24.45; P<.01), and 
a 56% cost reduction for the rest of their length of stay ($3.63 vs $8.17; 
P<.01).
Results:
•  Endometrial cancer patients who have robotic surgery experience less 
initial postoperative pain and have fewer drug interventions to manage 
their pain.  
•  The cost associated to deliver that care represents a savings of greater 
than 50% when compared to a laparoscopic cohort. 
•  These factors demonstrate the value of robotic surgery by delivering 
higher quality care at a lower cost.  
Conclusion:
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